Acute Promyelocytic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Promyelocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating a combination of lenalidomide, cytarabine, and idarubicin in adults with acute myeloid leukemia; the study…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: ASCT for Relapsed APL After Molecular Remission [Phase 2]
A Phase 2 trial evaluating autologous stem cell transplantation for relapsed Acute Promyelocytic Leukemia after molecular remission was term…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) [Phase 4]
A Phase 4 clinical trial evaluating arsenic trioxide for relapsed acute promyelocytic leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) [Phase 4]
Phase 4 clinical trial PETHEMA LPA 2005 for newly diagnosed acute promyelocytic leukemia has completed.
-
CLINICAL_TRIALS research · 2014-10-02Clinical Trial Update: Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia
This clinical trial update summarizes long-term quality-of-life outcomes in patients with Acute promyelocytic leukemia. The report does not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 trial update of combining sorafenib with vorinostat in poor-risk acute myeloid leukemia and high-risk myelodysplastic syndromes. The…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without gemtuzumab followed by tretinoin, mercaptopurine, and methotrexate or obse…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen for acute promyelocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Acute Promyelocytic Leukemia 2006 (APL) [Phase 3]
This is a Phase 3 clinical trial update for acute promyelocytic leukemia, sponsored by Assistance Publique - Hôpitaux de Paris, with the tri…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia [Phase 1]
A Phase 1 clinical trial evaluating tamibarotene in combination with arsenic trioxide for relapsed acute promyelocytic leukemia has been ter…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 study evaluating the combination of vorinostat with idarubicin in patients with relapsed or refractory leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of the combination therapy 7-Hydroxystaurosporine and perifosine in adults with relapsed or refractory acute leukemias, chroni…
-
CLINICAL_TRIALS research · 2013-09-25Clinical Trial Update: Proteasome Inhibition in Acute Promyelocytic Leukemia [Phase 2]
A Phase 2 clinical trial is investigating proteasome inhibition for relapsed acute promyelocytic leukemia, with the current status listed as…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]
A Phase 3 clinical trial compares combination chemotherapy with or without bone marrow transplantation for acute promyelocytic leukemia; the…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission [Phase 2]
Phase 2 trial evaluating a monoclonal antibody therapy in combination with chemotherapy for patients with acute promyelocytic leukemia in re…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]
This Phase 3 clinical trial compares tretinoin, cytarabine, and daunorubicin with or without arsenic trioxide, followed by tretinoin with or…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia [Phase 1]
A Phase 1 trial evaluating bortezomib in pediatric patients with refractory or recurrent leukemia, including blast-phase chronic myeloid leu…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
This entry reports a terminated clinical trial (NCT01463410) evaluating the accuracy of chromosomal aberration and gene mutation markers for…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated arsenic trioxide for patients with refractory or recurrent acute promyelocytic leukemia; the study is r…
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Homoharringtonine for patients with refractory acute promyelocytic leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL [Phase 2]
A Phase 2 study evaluating the safety, efficacy, and pharmacokinetics of tamibarotene in patients with relapsed or refractory acute promyelo…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…